LONDON (Thomson Financial) - Shares in Prelude Trust stood out among small
cap risers, advancing 9-1/4 pence -- or 12.7 percent -- to 82 as the company
announced proposals to dispose of its existing portfolio of early stage
technology based businesses and to wind up the company.
Cash proceeds to be returned to shares holders are estimated by Prelude at
around 86 pence a share.
An operations update lifted Frontera Resources 7-1/2 to 97-1/2, while Tepnel
Life Sciences edged up 0.625 to 9.625 after AstraZeneca extended an
agreement for Tepnel to supply it with DNA extraction services.
Tepnel will also have the opportunity to compete for further business with
AstraZeneca at volume-related discounts, the company said.
tf.TFN-Europe_newsdesk@thomson.com
fjb/jlw
COPYRIGHT
Copyright Thomson Financial News Limited 2008. All rights reserved.
The copying, republication or redistribution of Thomson Financial News Content,
including by framing or similar means, is expressly prohibited without the prior
written consent of Thomson Financial News.
|